van den Besselaar A M
Haemostasis and Thrombosis Research Centre, Leiden University Medical Centre, The Netherlands.
Thromb Haemost. 2000 Sep;84(3):410-2.
Oral anticoagulant therapy is usually monitored with the prothrombin time (PT) on citrate plasma samples. In recent years instruments have been developed for measurement of the PT in non-citrated whole blood. In the present study, the manufacturer's calibration of one type of device (CoaguChek) in terms of the international normalized ratio (INR) was evaluated by one laboratory. Three subsequent lots of test strips for the CoaguChek were investigated using blood samples from 56 coumarin-treated patients. Citrated plasma samples from the same patients were analysed with two international reference preparations for thromboplastin (IRP), i.e., rTF/95 (recombinant human) and RBT/90 (rabbit brain). There were statistically significant INR differences between CoaguChek and the international reference preparations (p <0.001), but the mean relative deviation of the INR was not greater than 0.104. Clinically relevant criteria were used to assess the agreement between the CoaguChek and the IRP results. Standard agreement ranged from 82% to 95%. It is concluded that these test strips achieved a clinically acceptable level of accuracy. Further studies of patient management with these strips are justified.
口服抗凝治疗通常通过检测枸橼酸盐血浆样本的凝血酶原时间(PT)来进行监测。近年来,已开发出用于检测非枸橼酸盐全血中PT的仪器。在本研究中,一个实验室对一种设备(CoaguChek)在国际标准化比值(INR)方面的制造商校准进行了评估。使用来自56例接受香豆素治疗患者的血样,对CoaguChek随后的三批测试条进行了研究。对来自同一患者的枸橼酸盐血浆样本,使用两种国际凝血活酶参考制剂(IRP)进行分析,即rTF/95(重组人源)和RBT/90(兔脑)。CoaguChek与国际参考制剂之间的INR存在统计学显著差异(p<0.001),但INR的平均相对偏差不大于0.104。采用临床相关标准评估CoaguChek与IRP结果之间的一致性。标准一致性范围为82%至95%。得出的结论是,这些测试条达到了临床上可接受的准确度水平。对使用这些测试条进行患者管理的进一步研究是合理的。